Oncology AbbVie Inc. (ABBV) Shares Slide as Revenue Beat and Raised 2026 Outlook Fail to Stem Sell-Off 7 days ago Shares of AbbVie Inc. (NYSE: ABBV) fell 6.5% to $210.93 on Wednesday, after the pharmaceutical leader reported fourth-quarter 2025 results.…